Edaravone, a potent free radical scavenger, reacts with peroxynitrite to produce predominantly 4-NO-edaravone

References

• Schmidley JW. Free radicals in central nervous system ischemia. Stroke 1990;21:1086–90. doi: 10.1161/01.STR.21.7.1086
   PubMed Web of Science ®Google Scholar
• Halliwell B. Reactive oxygen species and the central nervous system. J Neurochem 1992;59:1609–23. doi: 10.1111/j.1471-4159.1992.tb10990.x
   PubMed Web of Science ®Google Scholar
• Yamamoto Y, Kuwahara T, Watanabe K, Watanabe K. Antioxidant activity of 3-methyl-1-phenyl-2-pyrazolin-5-one (MCI-186). Redox Rep 1996;2:333–8.
   PubMed Web of Science ®Google Scholar
• Edaravone Acute Infarction Study Group. Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction: randomized, placebo-controlled, double-blind study at multicenters. Cerebrovasc Dis 2003;15:222–9. doi: 10.1159/000069318
   PubMed Web of Science ®Google Scholar
• Watanabe K, Watanabe K, Kuwahara T, Yamamoto Y. Free radical-induced oxidation products of 3-methyl-1-phenyl-2-pyrazolin-5-one (MCI-186). J Jpn Oil Chem Soc 1997;46:797–801. doi: 10.5650/jos1996.46.797
   Google Scholar
• Abe K, Yuki S, Kogure K. Strong attenuation of ischemic and postischemic brain edema in rats by a novel free radical scavenger. Stroke 1988;19:480–5. doi: 10.1161/01.STR.19.4.480
   PubMed Web of Science ®Google Scholar
• Shichinohe H, Kuroda S, Yasuda H, Ishikawa T, Iwai M, Horiuchi M, et al. Neuroprotective effects of the free radical scavenger edaravone (MCI-186) in mice permanent focal brain ischemia. Brain Res 2004;1029:200–6. doi: 10.1016/j.brainres.2004.09.055
   PubMed Web of Science ®Google Scholar
• Zhang N, Komine-Kobayashi M, Tanaka R, Liu M, Mizuno Y, Urabe T. Edaravone reduces early accumulation of oxidative products and sequential inflammatory responses after transient focal ischemia in mice brain. Stroke 2005;36:2220–5. doi: 10.1161/01.STR.0000182241.07096.06
   PubMed Web of Science ®Google Scholar
• Kawai H, Nakai H, Suga M, Yuki S, Watanabe T, Saito K. Effects of a novel free radical scavenger, MCl-186, on ischemic brain damage in the rat distal middle cerebral artery occlusion model. J Pharmacol Exp Ther 1997;281:921–7.
   PubMed Web of Science ®Google Scholar
• Yamamoto Y, Yanagisawa M, Tak NW, Watanabe K, Takahashi C, Fujisawa A, et al. Repeated edaravone treatment reduces oxidative cell damage in rat brain induced by middle cerebral artery occlusion. Redox Rep 2009;14:251–8. doi: 10.1179/135100009X12525712409779
   PubMed Web of Science ®Google Scholar
• Love S. Oxidative stress in brain ischemia. Brain Pathol 1999;9:119–31. doi: 10.1111/j.1750-3639.1999.tb00214.x
   PubMed Web of Science ®Google Scholar
• Szabó G, Loganathan S, Merkely B, Groves JT, Karck M, Szabó C, et al. Catalytic peroxynitrite decomposition improves reperfusion injury after heart transplantation. J Thorac Cardiovasc Surg 2012;143:1443–9. doi: 10.1016/j.jtcvs.2012.02.008
   PubMed Web of Science ®Google Scholar
• Suofu Y, Clark J, Broderick J, Wagner KR, Tomsick T, Sa Y, et al. Peroxynitrite decomposition catalyst prevents matrix metalloproteinase activation and neurovascular injury after prolonged cerebral ischemia in rats. J Neurochem 2010;115:1266–76. doi: 10.1111/j.1471-4159.2010.07026.x
   PubMed Web of Science ®Google Scholar
• Zhang L, Chen CL, Kang PT, Garg V, Hu K, Green-Church KB, et al. Peroxynitrite-mediated oxidative modifications of complex II: relevance in myocardial infarction. Biochemistry 2010;49:2529–39. doi: 10.1021/bi9018237
   PubMed Web of Science ®Google Scholar
• Walker LM, Walker PD, Imam SZ, Ali SF, Mayeux PR. Evidence for peroxynitrite formation in renal ischemia–reperfusion injury: studies with the inducible nitric oxide synthase inhibitor l-N(6)-(1-iminoethyl)lysine. J Pharmacol Exp Ther 2000;295:417–22.
   PubMed Web of Science ®Google Scholar
• Guven A, Uysal B, Akgul O, Cermik H, Gundogdu G, Surer I, et al. Scavenging of peroxynitrite reduces renal ischemia/reperfusion injury. Ren Fail 2008;30:747–54. doi: 10.1080/08860220802213039
   PubMed Web of Science ®Google Scholar
• Nauser T, Koppenol WH. The rate constant of the reaction of superoxide with nitrogen monoxide: approaching the diffusion limit. J Phys Chem A 2002;106:4084–6. doi: 10.1021/jp025518z
   Web of Science ®Google Scholar
• Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 2007;87:315–424. doi: 10.1152/physrev.00029.2006
   PubMed Web of Science ®Google Scholar
• Banno M, Mizuno T, Kato H, Zhang G, Kawanokuchi J, Wang J, et al. The radical scavenger edaravone prevents oxidative neurotoxicity induced by peroxynitrite and activated microglia. Neuropharmacology 2005;48:283–90. doi: 10.1016/j.neuropharm.2004.10.002
   PubMed Web of Science ®Google Scholar
• Dohare P, Hyzinski-García MC, Vipani A, Bowens NH, Nalwalk JW, Feustel PJ, et al. The neuroprotective properties of the superoxide dismutase mimetic tempol correlate with its ability to reduce pathological glutamate release in a rodent model of stroke. Free Radic Biol Med 2014;77:168–82. doi: 10.1016/j.freeradbiomed.2014.08.029
   PubMed Web of Science ®Google Scholar
• Santos CX, Anjos EI, Augusto O. Uric acid oxidation by peroxynitrite: multiple reactions, free radical formation, and amplification of lipid oxidation. Arch Biochem Biophys 1999;37:285–94. doi: 10.1006/abbi.1999.1491
   Web of Science ®Google Scholar
• Tsukada K, Hasegawa T, Tsutsumi S, Katoh H, Kuwano H, Miyazaki T, et al. Effect of uric acid on liver injury during hemorrhagic shock. Surgery 2000;127:439–46. doi: 10.1067/msy.2000.104486
   PubMed Web of Science ®Google Scholar
• Scott GS, Cuzzocrea S, Genovese T, Koprowski H, Hooper DC. Uric acid protects against secondary damage after spinal cord injury. Proc Natl Acad Sci U S A 2005;102:3483–8. doi: 10.1073/pnas.0500307102
   PubMed Web of Science ®Google Scholar
• Kato Y, Kawakishi S, Aoki T, Itakura K, Osawa T. Oxidative modification of tryptophan residues exposed to peroxynitrite. Biochem Biophys Res Commun 1997;234:82–4. doi: 10.1006/bbrc.1997.6587
   PubMed Web of Science ®Google Scholar
• Radi R. Peroxynitrite, a stealthy biological oxidant. J Biol Chem 2013;288:26464–72. doi: 10.1074/jbc.R113.472936
   PubMed Web of Science ®Google Scholar
• Carballal S, Bartesaghi S, Radi R. Kinetic and mechanistic considerations to assess the biological fate of peroxynitrite. Biochim Biophys Acta 2014;1840:768–80. doi: 10.1016/j.bbagen.2013.07.005
   PubMed Web of Science ®Google Scholar
• Kutzing MK, Firestein BL. Altered uric acid levels and disease states. J Pharmacol Exp Ther 2008;324:1–7. doi: 10.1124/jpet.107.129031
   PubMed Web of Science ®Google Scholar
• Keizman D, Ish-Shalom M, Berliner S, Maimon N, Vered Y, Artamonov I, et al. Low uric acid levels in serum of patients with ALS: further evidence for oxidative stress? J Neurol Sci 2009;285:95–9. doi: 10.1016/j.jns.2009.06.002
   PubMed Web of Science ®Google Scholar
• Yoshino H, Kimura A. Investigation of the therapeutic effects of edaravone, a free radical scavenger, on amyotrophic lateral sclerosis (Phase II study). Amyotroph Lateral Scler 2006;7:241–5. doi: 10.1080/17482960600881870
   PubMed Web of Science ®Google Scholar
• Nagase M, Yamamoto Y, Miyazaki Y, Yoshino H. Increased oxidative stress in patients with amyotrophic lateral sclerosis and the effect of edaravone administration. Redox Rep, 2015; [Epub ahead of print].
   PubMedGoogle Scholar